Ask a Question

Ask your question and our customer service team will answer it as soon as they can. Questions that do not contain personal information may be posted to our help center to be of service to others

* Required field

Your Email Address *

Please enter a valid email address.

Choose a Topic *

Tell us your question and any additional information *

Please enter all required fields.

Please Log In/Join Now first, and then use this function!

Considering a Clinical Study for Your Patients with Genitourinary Cancer?

As part of the Bristol Myers Squibb (BMS) commitment to patient care, we continue to explore bladder cancer, renal cell carcinoma, and prostate cancer through extensive clinical research.

divider

Jump to Studies

Bladder and Urinary Tract Cancers | Kidney Cancer | Prostate Cancer

Connect Eligible Patients with Appropriate Trials

Step 1: Review the Protocols and Determine Eligibility

Review trial details, including key inclusion/exclusion criteria, by clicking on the links in the "Jump to Studies" section above to determine the best trial for your patient.

Step 2: Talk to Your Patient

If you find a trial that your patient might qualify for, talk to them about clinical trial participation.

Step 3: Find Recruiting Site

Select a convenient site location from a list of participating clinical trial sites.

Step 4: Make Contact

Call the principal investigator to discuss eligibility and enrollment for your patient.

divider

Find a Genitourinary Cancer Clinical Study

Below you will find a list of clinical studies that are sponsored by Bristol Myers Squibb (BMS). Click the links to get more information about each study.

Bladder Cancer Clinical Studies

CA209-901

Recruiting

Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer

View Trial Details

CA209-8KX

Recruiting

A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

View Trial Details

CA017-078

Recruiting

A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

View Trial Details

Kidney Cancer Clinical Studies

CA209-67T

Recruiting

A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

View Trial Details

Prostate Cancer Clinical Studies

CA022-009

Recruiting

A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer

View Trial Details

Dig Deeper into Immuno-Oncology Research

I-O Quick Guide

A BMS-developed document written for patients to help explain how immuno-oncology works and how it is different from other therapies.

Learn More

divider

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Live support is available 24/7 - Call 855-907-3286 or email clinical.trials@bms.com

Have questions? Live support is available 24/7 -

Call 855-907-3286 or email clinical.trials@bms.com